𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Validation of the EORTC QLQ-C30 and EORTC QLQ-H&N35 in patients with laryngeal cancer after surgery

✍ Scribed by Susanne Singer; Dorit Wollbrück; Cornelia Wulke; Andreas Dietz; Eckart Klemm; Jens Oeken; Eberhard F. Meister; Hilmar Gudziol; Julian Bindewald; Reinhold Schwarz


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
128 KB
Volume
31
Category
Article
ISSN
1043-3074

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background.

The aim of this study was to test the validity of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire, Core Module (QLQ‐C30) and Head and Neck Module (QLQ‐H&N35) for patients who have undergone surgery due to laryngeal cancer.

Methods.

A total of 323 patients from 6 different centers in Germany who had been operated on completed the QLQ‐C30 and the QLQ‐H&N35 in addition to being surveyed in a personal interview.

Results.

Multitrait scaling analysis confirmed the proposed scale structure of both questionnaires. Cronbach's alpha of the QLQ‐C30 scales ranged from 0.64 (Cognitive Functioning) to 0.94 (Global Health Status); the alpha of the QLQ‐H&N35 ranged from 0.55 (Speech) to 0.90 (Sexuality). Known‐groups comparisons showed multiple differences in sociodemographic and clinical variables.

Conclusion.

It can be concluded that the QLQ‐H&N35, in conjunction with the QLQ‐C30, is a reliable instrument that is able to differentiate between diverse groups of patients with laryngeal cancer after surgery. © 2008 Wiley Periodicals, Inc. Head Neck, 2009


📜 SIMILAR VOLUMES


The EORTC core quality of life questionn
✍ Kyriaki Mystakidou; Eleni Tsilika; Efi Parpa; Ourania Kalaidopoulou; Vassilios S 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 French ⚖ 212 KB

In 1986, the European Organization for Research and Treatment (EORTC) initiated a research program to develop an integrated, modular approach for evaluating the quality of life of patients participating in international clinical trials. The questionnaire was designed to measure cancer patients' phys